Soratib 200 mg (containing Sorafenib) is an oral tyrosine kinase inhibitor (TKI) used to treat advanced kidney (renal cell carcinoma), liver (hepatocellular carcinoma), and thyroid cancers. It works by inhibiting multiple receptors to block angiogenesis (blood vessel formation) and tumor cell proliferation.